The authors concluded that, nowadays, there had been the evidence for an elevation in striatal dopaminergic D2/D3 receptor availability as a basis for increased dopaminergic neurotransmission in mania, and in depression—increased striatal dopamine transporter (DAT) leading to reduced dopaminergic function. Here, SLC6A3 is linked to depressive symptom measurement.